Literature DB >> 13340659

Pilot study of intra-articular procaine and hydrocortisone acetate in rheumatoid arthritis.

G R FEARNLEY, R LACKNER, R I MEANOCK, E G BYWATERS.   

Abstract

Entities:  

Keywords:  ADRENAL CORTEX/hormones; ARTHRITIS, RHEUMATOID/therapy; PROCAINE/therapeutic use

Mesh：

Substances：

Year:  1956        PMID： 13340659      PMCID： PMC1006868          DOI： 10.1136/ard.15.2.134

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  Value of intra-articular injections in osteo-arthritis.

Authors:  M H L DESMARAIS
Journal:  Ann Rheum Dis       Date:  1952-12       Impact factor: 19.103

2.  Deoxycortone and ascorbic acid in the treatment of rheumatoid arthritis.

Authors:  E G L BYWATERS; A St J DIXON; J B WILD
Journal:  Lancet       Date:  1950-05-20       Impact factor: 79.321
  2 in total
  5 in total

1.  Intra-articular therapy in osteo-arthritis; comparison of hydrocortisone acetate and hydrocortisone tertiary-butylacetate.

Authors:  V WRIGHT; G N CHANDLER; R A MORISON; S J HARTFALL
Journal:  Ann Rheum Dis       Date:  1960-09       Impact factor: 19.103

2.  Prednisolone trimethylacetate in intra-articular therapy.

Authors:  W R MURDOCH; G WILL
Journal:  Br Med J       Date:  1959-05-16

3.  Placebo responses in an arthritis trial.

Authors:  R A MORISON; A WOODMANSEY; A J YOUNG
Journal:  Ann Rheum Dis       Date:  1961-06       Impact factor: 19.103

4.  Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos.

Authors:  G Nuki; W W Downie; W C Dick; K Whaley; J B Spooner; M A Darby-Dowman; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1973-09       Impact factor: 19.103

Review 5.  DNA Methylation of T Lymphocytes as a Therapeutic Target: Implications for Rheumatoid Arthritis Etiology.

Authors:  Jianan Zhao; Kai Wei; Cen Chang; Lingxia Xu; Ping Jiang; Shicheng Guo; Steven J Schrodi; Dongyi He
Journal:  Front Immunol       Date:  2022-03-03       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.